Left ventricular assist device implantation following multisystem inflammatory syndrome in children due to SARS-CoV-2.
Oguz KonukogluAli DoganKenan SeverArzu AkcayMehmet BalkanayDenyan MansurogluPublished in: Journal of cardiac surgery (2022)
Multisystem inflammatory syndrome in children (MIS-C) is rare, however, severe hyperinflammatory condition in children generally weeks after acute SARS-CoV-2 infection. A subset of MIS-C patients is presented with severe heart failure. We hereby report 8-year-old girl presenting acute severe left ventricular failure. Various medical treatments including inotropic agents and drugs related to SARS-CoV-2 infection and MIS-C were applied. However, venoarterial extracorporeal membrane oxygenation (ECMO) was needed to be performed. Due to unsuccessful attempts for ECMO weaning, left ventricular assist device was implanted to the patient with temporary right ventricular support from ECMO.
Keyphrases
- extracorporeal membrane oxygenation
- left ventricular assist device
- acute respiratory distress syndrome
- respiratory failure
- heart failure
- case report
- sars cov
- left ventricular
- young adults
- mechanical ventilation
- drug induced
- end stage renal disease
- respiratory syndrome coronavirus
- early onset
- chronic kidney disease
- prognostic factors
- liver failure
- ejection fraction
- peritoneal dialysis
- hepatitis b virus
- acute myocardial infarction
- cardiac resynchronization therapy
- mitral valve
- coronary artery disease
- acute coronary syndrome
- hypertrophic cardiomyopathy
- aortic valve